<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02577068</url>
  </required_header>
  <id_info>
    <org_study_id>4-2015-0746</org_study_id>
    <nct_id>NCT02577068</nct_id>
  </id_info>
  <brief_title>Combination Effect of Nefopam With Propacetamol for Postoperative Pain After Thyroidectomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing thyroidectomy are suffering not only surgical wound pain but posterior
      neck pain because of neck extension position during the surgery. However, there has been
      little attention of posterior neck pain. Nefopam and Propacetamol have different
      pharmacodynamics and been used for postoperative pain control in thyroidectomy patients. The
      aim of this study is evaluation of combination effect of Nefopam and Propacetamol for acute
      wound pain, posterior neck pain and chronic pain after thyroidectomy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 15, 2015</start_date>
  <completion_date type="Actual">August 23, 2016</completion_date>
  <primary_completion_date type="Actual">August 23, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS score on wound site and posterior neck</measure>
    <time_frame>one hour after the surgery</time_frame>
    <description>Patients' subject pain score through VAS on the surgery wound site and posterior neck.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Additional pain rescue drug</measure>
    <time_frame>for postop. 24hrs.</time_frame>
    <description>how much of pain rescue drugs taken besides PCA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting</measure>
    <time_frame>for postop. 24hrs.</time_frame>
    <description>nausea score (0-none, 1- a little, 2- moderate, 3-severe) and vomiting (all or none)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>for postop. 24hrs.</time_frame>
    <description>Patients satisfaction score ( 0- dissatisfaction, 1- a little dissatisfaction, 2- average, 3- a little satisfaction, 4- satisfaction)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic pain and neurogenic pain</measure>
    <time_frame>three month after the surgery.</time_frame>
    <description>Neuropathic pain diagnostic questionnaire(DN 4) :
The DN4 questionnaire consists of a total of 10 items grouped in 4 sections. The first seven items are related to the quality of pain (burning, painful cold, electric shocks) and its association to abnormal sensations (tingling, pins and needles, numbness, itching). The other 3 items are related to neurological examination in the painful area (touch hypoesthesia, pinprick hypoesthesia, tactile allodynia). A score of 1 is given to each positive item and a score of 0 to each negative item. The total score is calculated as the sum of all 10 items, and the cut-off value for the diagnosis of neuropathic pain is a total score of 4/10. All questions are related to pain which is the claim for current medical consultation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>acute VAS on wound site and posterior neck</measure>
    <time_frame>postop. 24hrs.</time_frame>
    <description>VAS for patients' subject pain scor</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Thyroidectomy</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>nefopam group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>propacetamol group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>nefopam and propacetamol group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nefopam</intervention_name>
    <description>Patients undergoing thyroidectomy receive medications depending on the group allocation 30minutes prior to the surgery end; Nefopam 20mg, Propacetamol 2g, and Nefopam 20mg+Propacetamol 2g. In addition, patients will take the same medication every six hours during POD 1.</description>
    <arm_group_label>nefopam and propacetamol group</arm_group_label>
    <arm_group_label>nefopam group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propacetamol</intervention_name>
    <description>Patients undergoing thyroidectomy receive medications depending on the group allocation 30minutes prior to the surgery end; Nefopam 20mg, Propacetamol 2g, and Nefopam 20mg+Propacetamol 2g. In addition, patients will take the same medication every six hours during POD 1.</description>
    <arm_group_label>nefopam and propacetamol group</arm_group_label>
    <arm_group_label>propacetamol group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient who undergone open thyroidectomy

          -  20~70 years old

          -  ASA I~III

        Exclusion Criteria:

          -  hypersensitivity on Nefopam and Propacetamol

          -  Liver failure, chronic alcohol addiction

          -  severe hemolytic anemia, chronic nutrition deficiency

          -  history of seizure

          -  MI, MAO inhibitor

          -  pregnant, breast-feeding

          -  foreigners
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Han DW, Koo BN, Chung WY, Park CS, Kim SY, Palmer PP, Kim KJ. Preoperative greater occipital nerve block in total thyroidectomy patients can reduce postoperative occipital headache and posterior neck pain. Thyroid. 2006 Jun;16(6):599-603.</citation>
    <PMID>16839262</PMID>
  </reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>October 6, 2015</study_first_submitted>
  <study_first_submitted_qc>October 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2015</study_first_posted>
  <last_update_submitted>March 19, 2019</last_update_submitted>
  <last_update_submitted_qc>March 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propacetamol</mesh_term>
    <mesh_term>Nefopam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

